Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling
Wei Wang(China Medical University), Xueshan Qiu(First Hospital of China Medical University)
Cited by 33
Related Papers
Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer
|Cancer Science|2010|340
Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment
|Pharmaceutics|2021|92
LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1
|Cell Death and Disease|2022|62